ROSSIN, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 4.332
EU - Europa 437
AS - Asia 260
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.036
Nazione #
US - Stati Uniti d'America 4.331
SG - Singapore 188
IT - Italia 90
IE - Irlanda 76
DE - Germania 68
RU - Federazione Russa 53
CN - Cina 46
UA - Ucraina 37
GB - Regno Unito 30
FR - Francia 23
FI - Finlandia 15
CZ - Repubblica Ceca 13
KR - Corea 10
SE - Svezia 10
PL - Polonia 8
DK - Danimarca 6
BE - Belgio 4
CL - Cile 2
EU - Europa 2
HK - Hong Kong 2
IN - India 2
IR - Iran 2
JP - Giappone 2
KG - Kirghizistan 2
NL - Olanda 2
TW - Taiwan 2
VN - Vietnam 2
AR - Argentina 1
BR - Brasile 1
CA - Canada 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
LK - Sri Lanka 1
TR - Turchia 1
Totale 5.036
Città #
Wilmington 1.183
Houston 1.109
Woodbridge 812
Fairfield 214
Chandler 174
Singapore 168
Ashburn 104
Ann Arbor 85
Seattle 75
Cambridge 68
Dublin 63
Rome 49
Medford 48
Santa Clara 41
Jacksonville 28
New York 24
Lawrence 22
Beijing 20
Munich 19
Dearborn 17
Creede 15
San Diego 15
Menlo Park 14
Brno 13
Kraków 8
Moscow 7
Lappeenranta 6
London 5
Seoul 5
Brussels 4
Cagliari 4
Guangzhou 4
Zhengzhou 4
Kunming 3
Mountain View 3
Redwood City 3
Saint Petersburg 3
Beaverton 2
Bologna 2
Chengdu 2
Chiswick 2
Copenhagen 2
Hanoi 2
Hefei 2
Helsinki 2
Hounslow 2
Kaohsiung 2
Mcallen 2
Milan 2
Nanchang 2
Norwalk 2
Padova 2
Redmond 2
Washington 2
Amsterdam 1
Atlanta 1
Boardman 1
Buffalo 1
Büdelsdorf 1
Colombo 1
Council Bluffs 1
Esslingen am Neckar 1
Falls Church 1
Formia 1
Hangzhou 1
Kilburn 1
Lansing 1
Loughborough 1
L’Aquila 1
Madrid 1
Melegnano 1
Montreal 1
Munro 1
Mülheim 1
Nagpur 1
Nanjing 1
Nanning 1
Osaka 1
Osasco 1
Palo Alto 1
Philadelphia 1
Pune 1
Quito 1
Saint Louis 1
San Cesareo 1
San Francisco 1
San Mateo 1
San Pietro al Tanagro 1
Shanghai 1
Shaoxing 1
Siena 1
Southend 1
Suzhou 1
Turin 1
University Park 1
Verona 1
Yellow Springs 1
Zibo 1
Totale 4.517
Nome #
The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation 408
Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions. 396
Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins 390
Assessing the Catalytic Activity of Transglutaminases in the Context of Autophagic Responses. 382
Reticulon protein-1C is a key component of MAMs 343
Transglutaminase type 2: a multifunctional protein chaperone? 330
TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy 329
TG2 regulates the heat-shock response by the post-translational modification of HSF1. 319
Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection 305
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease. 298
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2. 269
Transglutaminase type 2 in the regulation of proteostasis. 185
Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75 182
Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis 165
Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease 161
ROLE FOR RETICULON-1C IN SKELETAL MUSCLE DIFFERENTIATION 105
Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis 64
null 62
Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins and damaged mitochondria 57
Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis 56
Transglutaminase Type 2 regulates the Wnt/β-catenin pathway in vertebrates 50
Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois 41
Transglutaminase Type 2 is Involved in the Hematopoietic Stem Cells Homeostasis 38
Cysteamine with in vitro antiviral activity and immunomodulatory effects has the potential to be a repurposing drug candidate for covid-19 therapy 26
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma 23
Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin 22
Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis 20
The role of transglutaminase type 2 in the regulation of autophagy 19
Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation 19
The multifaceted role of HSF1 in pathophysiology: Focus on its interplay with TG2 18
Celiac disease TG2 autoantibodies development: it takes two to tango 18
Transglutaminase 2 and Ferroptosis: a new liaison? 14
Transglutaminase type 2-dependent crosslinking of IRF3 in dying melanoma cells 13
Transglutaminase type 2: A multifunctional protein chaperone? 12
The STING/TBK1/IRF3/IFN type I pathway is defective in cystic fibrosis 12
Type 2 transglutaminase in the nucleus: the new epigenetic face of a cytoplasmic enzyme 7
Reticulon-1c involvement in muscle regeneration 2
Totale 5.160
Categoria #
all - tutte 15.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020869 0 0 0 0 0 119 114 110 202 115 105 104
2020/2021978 115 116 103 104 91 103 130 116 35 27 30 8
2021/2022236 15 24 5 4 1 17 23 28 26 15 18 60
2022/2023463 24 48 3 54 48 71 62 32 43 0 20 58
2023/2024193 31 10 15 7 33 39 4 6 3 6 4 35
2024/2025340 27 158 87 31 31 6 0 0 0 0 0 0
Totale 5.160